Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness.
"Sinopsis" puede pertenecer a otra edición de este libro.
Librería: PBShop.store US, Wood Dale, IL, Estados Unidos de America
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9786208427764
Cantidad disponible: Más de 20 disponibles
Librería: PBShop.store UK, Fairford, GLOS, Reino Unido
PAP. Condición: New. New Book. Shipped from UK. Established seller since 2000. Nº de ref. del artículo: L2-9786208427764
Cantidad disponible: Más de 20 disponibles
Librería: California Books, Miami, FL, Estados Unidos de America
Condición: New. Nº de ref. del artículo: I-9786208427764
Cantidad disponible: Más de 20 disponibles
Librería: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware 188 pp. Englisch. Nº de ref. del artículo: 9786208427764
Cantidad disponible: 2 disponibles
Librería: CitiRetail, Stevenage, Reino Unido
Paperback. Condición: new. Paperback. Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability. Nº de ref. del artículo: 9786208427764
Cantidad disponible: 1 disponibles
Librería: preigu, Osnabrück, Alemania
Taschenbuch. Condición: Neu. Formulation and Optimization of Transdermal Patches | A brief study | Mukesh Rani (u. a.) | Taschenbuch | Englisch | 2025 | LAP LAMBERT Academic Publishing | EAN 9786208427764 | Verantwortliche Person für die EU: SIA OmniScriptum Publishing, Brivibas Gatve 197, 1039 RIGA, LETTLAND, customerservice[at]vdm-vsg[dot]de | Anbieter: preigu. Nº de ref. del artículo: 134022213
Cantidad disponible: 5 disponibles
Librería: buchversandmimpf2000, Emtmannsberg, BAYE, Alemania
Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 188 pp. Englisch. Nº de ref. del artículo: 9786208427764
Cantidad disponible: 1 disponibles
Librería: AHA-BUCH GmbH, Einbeck, Alemania
Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Lisinopril is an antihypertensive agent indicated for the prevention of hypertension, acute myocardial infarction and diabetic nephropathy. It is an angiotensin converting enzyme(ACE) inhibitor. It has a short half-life and undergoes variable first pass metabolism. It is required to be administered two or three times daily which results in poor patient compliance. In this work an attempt was made to formulate & evaluate TDDS for sustained release of lisinopril by solvent evaporation method. Low molecular weight, good permeability and shorter half-life of the drug made it a suitable candidate for the development of trans dermal patch.The main objective of formulating the transdermal system was to prolong the drug release time, reduce the frequency of administration and to improve patient compliance. The compatibility characterization was done by IR method. By using 32factorial design nine formulations were prepared using hydrophilic (HPMC) andhydrophobic (ethyl cellulose) polymers along with selected plasticizer & permeationenhancer. PVA backing membrane was used as a substrate for pouring the polymeric solution. The prepared patches were evaluated for physical appearance, thickness. Nº de ref. del artículo: 9786208427764
Cantidad disponible: 2 disponibles
Librería: Books Puddle, New York, NY, Estados Unidos de America
Condición: New. Print on Demand. Nº de ref. del artículo: 26405258389
Cantidad disponible: 4 disponibles
Librería: Majestic Books, Hounslow, Reino Unido
Condición: New. Print on Demand. Nº de ref. del artículo: 407928650
Cantidad disponible: 4 disponibles